R1 RCM Inc

R1 RCM — Q3 2022 Earnings Presentation

14 slides from R1 RCM's earnings presentation, Nov 8, 2022

  1. Slide 1: Third Quarter 2022 Earnings Call

    November 8, 2022 Third Quarter 2022 Earnings Call NEED NEW IMAGE THAT WE SENT Exhibit 99.2

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements This presentation includes information that may constitute “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking s

  3. Slide 3: Third Quarter 2022 Results

    Third Quarter 2022 Results Revenue of $496.0 million was up $116.3 million or 30.6%, compared to the same period last year GAAP net loss of $29.5 million, compared to GAAP net income of $17.0 million in the same period last year, negatively impacted by a $9.5 million increase in allowance for credit

  4. Slide 4: Updated 2022 Guidance and 2023 Views

    Updated 2022 Guidance and 2023 Views Lowering 2022 revenue guidance to a range of $1,790 million to $1,800 million and Adjusted EBITDA1 guidance to $420 million to $425 million Q4 guidance anticipates: Modest recovery in incentive fees from Q3 levels Lower net operating fees due to lower than antici

  5. Slide 5: Operational Update

    Operational Update Demand remains strong, driven by ongoing labor-driven challenges faced by providers Several integration components complete, including establishment of a modular commercial organization, consolidation of product and technology groups, and integration of HR systems Continue to adva

  6. Slide 6: Key Drivers of Long-Term Growth Remain Intact

    Key Drivers of Long-Term Growth Remain Intact Strong Value Proposition and Competitive Differentiation $13B+ in new NPR signed onto end-to-end platform in 2022 Cloudmed’s industry-leading revenue intelligence platform has unparalleled scale, serving 40% of provider NPR across the country End-market

  7. Slide 7: Leadership Succession

    Leadership Succession Lee Rivas appointed CEO and will join R1’s Board of Directors effective January 1, 2023 President of R1 since June 2022 Former CEO of Cloudmed 20+ years of leadership experience in technology and healthcare Joe Flanagan to step down from CEO role effective January 1, 2023 Joe t

  8. Slide 8: Q3'22 Non-GAAP Results – Q/Q and Y/Y Comparison

    Q3’22 Non-GAAP Results – Q/Q and Y/Y Comparison Note1: Adjusted Cost of Services, Adjusted SG&A expense, and Adjusted EBITDA are non-GAAP measures. A reconciliation of non-GAAP to GAAP measures is provided in the Appendix of this presentation. ($ in millions) Q3'22 Q2'22 Q3'21 Key change driver(s) R

  9. Slide 9: Additional Commentary

    Additional Commentary Cash and cash equivalents of $131.1 million as of 9/30/2022, compared to $163.5 million as of 6/30/2022 Cash flow from operations of $26.0 million Repaid $14.3 million of debt and repurchased ~$12 million worth of shares Balance sheet and liquidity position remain strong Net de

  10. Slide 10: Appendix

    Nf endix i] Ap

  11. Slide 11: Contract Economics by Engagement Model

    Contract Economics by Engagement Model EBITDA margin3 IDN Operating Partner Co-Managed Modular Engagement Type Commentary Illustrative Economics ($M)1 R1 manages end-to-end RCM capabilities Requires extensive infrastructure to execute Greatest revenue opportunity, high growth potential Highest Adjus

  12. Slide 12: Financial Model for Operating Partner Model

    Financial Model for Operating Partner Model Illustrative Contribution from $3B NPR IDN Customer Growth Deploy transition resources Perform financial assessment Invest in infrastructure Implement technology Finalize employee transitions to steady state org structure Complete standardization Deploy au

  13. Slide 13: Use of Non-GAAP Financial Measures

    Use of Non-GAAP Financial Measures 2022 GAAP Operating Income Guidance $(8)-(13) Plus: Depreciation and amortization expense $170-175 Share-based compensation expense $70-75 CoyCo 2 share-based compensation expense $5-7 Strategic initiatives, severance and other costs $180-185 Adjusted EBITDA Guidan

  14. Slide 14: Reconciliation of Non-GAAP Financial Measures

    Reconciliation of Non-GAAP Financial Measures $ in millions Reconciliation of GAAP Net Income to Non-GAAP Adjusted EBITDA Reconciliation of GAAP SG&A Expenses to Non-GAAP SG&A Expenses Reconciliation of GAAP Cost of Services to Non-GAAP Cost of Services Note1: Other expenses are comprised of strateg

R1 RCM — Q3 2022 Earnings Presentation on 6ix